Herpesvirus Reactivation and Socioeconomic Position: a Community-based Study

Overview

Journal J Epidemiol Community Health

Specialty Health Services

Date 2009 Oct 15

PMID 19825788

Citations 30

Authors

Raymond P Stowe

M Kristen Peek

Norma A Perez

Deborah L Yetman

Malcolm P Cutchin

James S Goodwin

Affiliations

Soon will be listed here.

Abstract

Background: Elevated antibodies to latent herpesviruses have been demonstrated to be a reliable marker of diminished cellular immunity and recently have been associated with low socioeconomic position (SEP) in older adults. Extending these observations in a community-based study over a wide age range would provide an important new direction for investigating mechanisms underlying poor health outcomes in individuals with low SEP.

Methods: Anti-herpes simplex virus (HSV)-1 and anti-Epstein-Barr virus (EBV) antibodies were measured in blood samples from 1457 adults aged 25-90. Regression models were then used to determine the relationships between viral reactivation, age, gender, ethnicity and SEP.

Results: Individuals were significantly more likely to have higher antiviral antibodies (ie, reactivation) to both EBV and HSV-1 than one virus alone. Individuals in the lowest age group had less reactivation, whereas greater reactivation was observed in women and those with the least education. Compared to white non-Hispanics, Hispanics and black non-Hispanics experienced more viral reactivation. These relationships remained strong after controlling for sociodemographic factors as well as smoking status, body mass index and physical activity.

Conclusions: These results demonstrate that herpesvirus reactivation is associated with variables such as age, gender, ethnicity and education, and may play a role in poorer health outcomes in both younger and older adults.

Citing Articles

Early Life Adversity, Microbiome, and Inflammatory Responses.

Beurel E, Nemeroff C Biomolecules. 2024; 14(7).

PMID: 39062516 PMC: 11275239. DOI: 10.3390/biom14070802.

Relationship satisfaction determines the association between Epstein-Barr virus latency and somatic symptoms after the loss of a spouse.

LeRoy A, Petit W, Brown R, Murdock K, Garcini L, Stowe R Pers Relatsh. 2023; 27(3):652-673.

PMID: 36685314 PMC: 9854169. DOI: 10.1111/pere.12336.

Antibodies to Human Herpesviruses and Rate of Incident Cardiovascular Events and All-Cause Mortality in the UK Biobank Infectious Disease Pilot Study.

Chu P, Cadogan S, Warren-Gash C Open Forum Infect Dis. 2022; 9(7):ofac294.

PMID: 35873304 PMC: 9301583. DOI: 10.1093/ofid/ofac294.

Examination of control asymptomatic cohorts reveals heightened anti-EBV and HHV-6 A/B dUTPase antibodies in the aging populations.

Alharshawi K, Cox B, Ariza M J Med Virol. 2022; 94(7):3464-3468.

PMID: 35315111 PMC: 9117428. DOI: 10.1002/jmv.27728.

Immune and Epigenetic Pathways Linking Childhood Adversity and Health Across the Lifespan.

Chen M, LeRoy A, Majd M, Chen J, Brown R, Christian L Front Psychol. 2021; 12:788351.

PMID: 34899540 PMC: 8662704. DOI: 10.3389/fpsyg.2021.788351.

References

Glaser R, Strain E, Tarr K, Holliday J, DONNERBERG R, Kiecolt-Glaser J . Changes in Epstein-Barr virus antibody titers associated with aging. Proc Soc Exp Biol Med. 1985; 179(3):352-5. DOI: 10.3181/00379727-179-42108. View

Dowd J, Haan M, Blythe L, Moore K, Aiello A . Socioeconomic gradients in immune response to latent infection. Am J Epidemiol. 2007; 167(1):112-20. DOI: 10.1093/aje/kwm247. View

Arvin A . Varicella-zoster virus. Clin Microbiol Rev. 1996; 9(3):361-81. PMC: 172899. DOI: 10.1128/CMR.9.3.361. View

Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth J, Sinclair A . Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002; 169(4):1984-92. DOI: 10.4049/jimmunol.169.4.1984. View

Trzonkowski P, Mysliwska J, Szmit E, Wieckiewicz J, Lukaszuk K, Brydak L . Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence. Vaccine. 2003; 21(25-26):3826-36. DOI: 10.1016/s0264-410x(03)00309-8. View

Tan L, Gudgeon N, Annels N, Hansasuta P, OCallaghan C, Rowland-Jones S . A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol. 1999; 162(3):1827-35. View

Gillespie G, Wills M, Appay V, OCallaghan C, Murphy M, Smith N . Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol. 2000; 74(17):8140-50. PMC: 112348. DOI: 10.1128/jvi.74.17.8140-8150.2000. View

KATCHER A, Brightman V, Luborsky L, Ship I . Prediction of the incidence of recurrent herpes labialis and systemic illness from psychological measurements. J Dent Res. 1973; 52(1):49-58. DOI: 10.1177/00220345730520013501. View

Wikby A, Ferguson F, Forsey R, Thompson J, Strindhall J, Lofgren S . An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci. 2005; 60(5):556-65. DOI: 10.1093/gerona/60.5.556. View

10.

Weymouth L, Gomolin I, Brennan T, Sirpenski S, Mayo D . Cytomegalovirus antibody in the elderly. Intervirology. 1990; 31(2-4):223-9. DOI: 10.1159/000150157. View

11.

Nielsen T, Pedersen M, Rostgaard K, Frisch M, Hjalgrim H . Correlations between Epstein-Barr virus antibody levels and risk factors for multiple sclerosis in healthy individuals. Mult Scler. 2007; 13(3):420-3. DOI: 10.1177/1352458506071470. View

12.

Stowe R, Kozlova E, Yetman D, Walling D, Goodwin J, Glaser R . Chronic herpesvirus reactivation occurs in aging. Exp Gerontol. 2007; 42(6):563-70. PMC: 1992441. DOI: 10.1016/j.exger.2007.01.005. View

13.

Wagner H, Hornef M, Teichert H, Kirchner H . Sex difference in the serostatus of adults to the Epstein-Barr virus. Immunobiology. 1994; 190(4-5):424-9. DOI: 10.1016/S0171-2985(11)80613-3. View

14.

Musiani M, Zerbini M, Zauli D, Cometti G, La Placa M . Impairment of cytomegalovirus and host balance in elderly subjects. J Clin Pathol. 1988; 41(7):722-5. PMC: 1141576. DOI: 10.1136/jcp.41.7.722. View

15.

Okano M, Thiele G, Davis J, Grierson H, Purtilo D . Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev. 1988; 1(3):300-12. PMC: 358052. DOI: 10.1128/CMR.1.3.300. View

16.

Stowe R, Mehta S, Ferrando A, Feeback D, Pierson D . Immune responses and latent herpesvirus reactivation in spaceflight. Aviat Space Environ Med. 2001; 72(10):884-91. View

17.

Wikby A, Nilsson B, Forsey R, Thompson J, Strindhall J, Lofgren S . The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev. 2006; 127(8):695-704. DOI: 10.1016/j.mad.2006.04.003. View

18.

Glaser R, Kiecolt-Glaser J . Chronic stress modulates the virus-specific immune response to latent herpes simplex virus type 1. Ann Behav Med. 1997; 19(2):78-82. DOI: 10.1007/BF02883323. View

19.

Peek M, Cutchin M, Freeman D, Stowe R, Goodwin J . Environmental hazards and stress: evidence from the Texas City Stress and Health Study. J Epidemiol Community Health. 2009; 63(10):792-8. PMC: 3856671. DOI: 10.1136/jech.2008.079806. View

20.

Peek M, Cutchin M, Freeman D, Perez N, Goodwin J . Perceived health change in the aftermath of a petrochemical accident: an examination of pre-accident, within-accident, and post-accident variables. J Epidemiol Community Health. 2008; 62(2):106-12. PMC: 3856660. DOI: 10.1136/jech.2006.049858. View